Fras JP, Auerbach P, Bajaj HS et al (2021) Efficacy and safety of once-weekly semaglutide 2.0 mg versus 1.0 mg in patients with type 2 diabetes (SUSTAIN FORTE): a double-blind, randomised, phase 3B trial
Following an overview of the epidemiology, biology, consequences, and treatments of ASUDs, this review provides a summary of the emerging role of GLP-1RAs in the treatment of ASUDs by elucidating their interactions with various neurobiological pathways involved in addiction
BMJ (2023)
Using clinically studied ingredients, this natural GLP-1 support supplement works with your bodys natural signaling systems to help restore balance from within
Frequently Asked Questions: What are GLP-1 receptor agonists (GLP-1 RAs)
Hypoglycemia: The risk is less with GLP-1 RAs